ical immunohistochemical detection and localization of porcine reproductive and respiratory syndrome virus in gnotobiotic pigs. Vet Pathol 33:551-556. 18 Actinobacillus pleuropneumoniae is a primary cause of swine pleuropneumonia, a severe and contagious disease that causes important economical losses. 18 Using various serologic methods and polyclonal antibodies, A. pleuropneumoniae can be grouped into 12 NAD-dependant serotypes; serotypes 1 and 5 represent most isolates recovered from acute cases of pleuropneumonia in North America. 4, 15 Several techniques have been described for the serologic characterization of A. pleuropneumoniae, such as tube and slide agglutination, ring and slide precipitation, counterimmunoelectrophoresis, indirect hemagglutination, coagglutination, immunodiffusion, and immunofluorescence. 15, 21 Inconsistent results, however, are sometimes found in serotyping of isolates because antigens or antisera used in these assays have not been well characterized. A common problem in the serologic classification of A. pleuropneumoniae has been the reactivity of some isolates with more than 1 of the polyclonal serotypespecific antisera. 8 In particular, cross-reactions have been observed among serotypes 3, 6, and 8, among serotypes 1, 9, and 11, and between serotypes 4 and 7. 13, 14, 16, 20 Thus, the need for adsorption of sera complicates the precise identification of the serotype involved. In addition, some Haemophilus parasuis and Actinobacillus suis strains may present cross-reactions with A. pleuropneumoniae. 6, 13 The use of serotype-specific monoclonal antibodies (MAbs) could help overcome these problems. In addition, MAbs may be used for a more precise characterization of antigens involved in From Groupe de Recherche sur les Maladies Infectieuses du Port, Département de pathologie et microbiologic, Faculté de médecine vétérinaire, Université de Montreal, CP 5000, Saint-Hyacinthe, PQ J2S 7C6, Canada.
Received for publication October 14, 1996. the classification of A. pleuropneumoniae. Previous reports mentioned the characterization of A. pleuropneumoniae MAbs, but few data are available on the specificity and sensitivity of these MAbs when testing a large number of field isolates. 5, 12 The aim of this study is to report the production and characterization of type-specific MAbs for the serotyping of A. pleuropneumoniae serotypes 1 and 5 field strains. A field strain of A. pleuropneumoniae of serotype 1, FMV87-682, and the reference strain 81-750 and field strain 91-178-2005 of serotype 5b were used for the production of MAbs in different fusions. The strain FMV87-682 was selected because it did not react with the serotype-specific MAb 1.5 C5 F4 (Table 1) ; 11 this MAb was also included in this study. Strain 91-178-2005 was chosen because it failed to react with the MAb 4.4C6.F7 (Table 1 ). Reference strains of serotypes 1-12 used for the selection of hybriodomas were obtained from a stock culture collection. MAbs were produced by immunizing Balb/c mice intraperitoneally with formalinized whole cell antigen (WCA) prepared as previously described. 11 The spleen-cells were fused with the SP2/O-Ag 14 or NSI/ I-Ag-4-1 myeloma cells using polyethylene glycol 1500. a The screening was carried out by an indirect enzyme-linked immunosorbent assay (IELISA) as previously described 11 using WCA of the homologous strains. Selected hybridomas were cloned, and the immunoglobulin classes were identified with an antibody isotyping kit. a Selected MAbs were tested by iELISA for their specificity to serotypes 1 or 5 using the WCA of the reference strains of all 12 serotypes. Epitopes recognized by each of the selected serotype-specific MAbs were studied by testing their reactivity with different antigens in ELISA and immunoblot. 6 Different antigens consisted of WCA and O-chain lipopolysaccharide (LPS), purified as previously described. 7 In addition, for serotype 5, purified capsular polysaccharidel was used. Serotype 5 strains 545 and its noncapsulated mutant were also tested for some MAbs. MAbs were also tested after treatment of the different antigens with proteinase K (100 µg/ml, 1 hour, 55 C) or sodium periodate (5 mM NaIO 4 ). 23 Electron microscopy after immunostabilization of the capsule was carried out as previously described. 9 A total of 10 hybridomas from 5 fusions were selected. Of these, 1 clone specifically directed against serotype 1 (MAb F11-7F) and 2 clones specifically directed against serotype 5 (MAbs 4.4C6.F7 and 6.1E7.E3) were chosen for further studies (Table 1 ). These MAbs did not recognize other bacterial species, such as A. lignieresii, A. suis, A. rossii, Haemophilus spp., H. parasuis, Pasteurella multocida, P. suis, Bordetella bronchiseptica, and Eschericha coli.
The MAb F11-7F reacted specifically with the WCA of A. pleuropneumoniae serotype 1, even after its treatment with proteinase K. The reaction, however, disappeared after antigen treatment with sodium periodate, and no reaction could be detected when purified O-chain LPS was used. Immunoblot results (Fig. la) showed a clear reaction in the highmolecular-weight region of the WCA, which corresponds to the capsule. These results were confirmed by immunoelectron microscopy; this MAb stabilized the capsule in a manner similar to that of MAb 1.5 C5 F4 ( Fig. 2a, 2b) .
Serotype 5-specific MAbs 4.4C6.F7 and 6.1E7.E3 also recognized a carbohydrate epitope; they reacted with both untreated and proteinase K-treated WCA but not with the sodium periodate-treated WCA. By immunoblot, both MAbs reacted similarly with the WCA in the high-molecular-weight region (Fig. 1b) . The epitope was not located in the capsule; both MAbs reacted with both the parent 545 strain and its noncapsulated mutant. Also, a negative result was obtained by ELISA with purified capsular polysaccharides, and they failed to stabilize the capsule (results not shown). However, both MAbs reacted with the purified O-chain LPS by ELISA and immunoblot (Fig. 1b) .
To examine the suitability of these MAbs for serotyping, a total of 532 field isolates of A. pleuropneumoniae (419 isolates from lungs, 113 isolates from tonsils) were tested ( Table 2) . All the isolates from lungs originated from Canada from clinical cases of swine pleuropneumonia, with the exception of those of serotypes 4, 9, and 11, which have not been isolated in North America and came from cases of acute swine pleuropneumonia in Europe. Some of the serotype 1 isolates were confirmed as belonging to either serotype la or serotype 1b. 10 (NAD independent). Isolates from tonsils were recovered from carrier animals in different herds subclinically infected (without presence of any clinical signs and/or lesions at slaughter), using a selective medium. 22 All the isolates were tested by coagglutination, immunodiffusion, counterimmunoelectrophoresis, and indirect hemagglutination tests using polyclonal antibodies as previously described. 15 MAbs were used in parallel to test all isolates by dot ELISA, which was performed as follows. WCA suspensions adjusted to Mc-Farland no. 4 were placed on nitrocellulose membranes in a 10-µl volume and incubated at room temperature for 15 minutes. Membranes were rinsed with Tris-NaCl buffer and blocked for 1 hour in 2% casein-Tris-NaCl buffer. A 2-hour Table 2 . Serotype distribution of Actinobacillus pleuropneumoniae field isolates tested. incubation of the membranes with MAbs (separately or in idase. b The membranes were then transferred to a solution combination) optimally diluted in 2% casein-Tris-NaCl buffof chloronaphthol (2.8 mM) in 16% (v/v) methanol Triser was followed by a 1-hour incubation of optimally diluted NaCl buffer. goat anti-mouse IgG + 1gM (H + L) conjugated to perox-Serotyping results of the field isolates with polyclonal se- rum-based conventional tests and the dot ELISA using the MAbs are shown in Table 3 . MAb 1.5 C5 F4 recognized 88% of isolates from clinical cases of pleuropneumonia. This percentage is lower than that obtained in a previous study (99%) using fewer strains. 11 In addition in this study almost half of the isolates from carrier animals were negative, indicating some antigenic differences between the 2 groups of isolates. This is the first study of MAbs directed to A. pleuropneumoniae where a relatively large number of isolates from carrier animals were tested. MAb F11 -7F, produced from a strain that did not react with MAb 1.5 C5 F4, recognized most of both groups of isolates. Epitopes recognized by serotype 1 MAbs seem to be present in isolates in a complementary way; a combination of both MAbs detected 100% of serotype 1 isolates. Because both MAbs were directed to the capsule, these results indicate that isolates from carrier animals and from clinical cases of pleuropneumonia are capsulated. Similar results were obtained with serotype 5-specific MAbs; a combination of both MAbs recognized 100% of the A. pleuropneumoniae isolates (serotypes 5a, 5b) (Table 3) . Isolates from clinical cases or carrier animals reacted in a similar way with both MAbs. These results confirmed those of previous reports, which indicated that the O-chain LPS of serotype 5 possesses serotype-specific antigens. 3, 7, 17 Because differences between serotypes 5a and 5b seem to be at the capsule level, 1 the MAbs did not differentiate between the two subtypes. These results also confirmed that some epitopes of the LPS (specifically the O chain) may be exposed on the bacterial surface; 19 untreated whole cells reacted equally well in the dot ELISA.
Most previous studies of A. pleuropneumoniae-specific MAbs, with the exception of 1 study of serotype 5 strains, 2 included only a limited number of field isolates. One group of authors 12 mentioned that when more A. pleuropneumoniae isolates are tested with the MAbs, disagreements with conventional methods are obtained, especially in the case of serotype 1. In the present study, field isolates from acutely infected or clinically healthy animals could be easily and correctly serotyped using a combination of MAbs obtained after 2 sets of fusions. Because several techniques were used for typing some of the serotype 1 isolates from tonsils (un-published observations), serotyping results were not available before 1 week; however, these strains were easily identified in a few hours by dot ELISA with the MAbs. In addition, the use of MAbs will eliminate the problem of interpretation frequently observed with polyclonal antibodies because of cross-reactions. The panel of MAbs described in this study may be very useful for serotyping field isolates of A. pleuropneumoniae serotypes 1 and 5, which are the most important serotypes in North America.
